Bill Text — Jul 22, 2011
This bill’s text for status Reported by Senate Committee (Jul 22, 2011) is now available.
Jan 17, 2007
110th Congress, 2007–2009
This bill was introduced on February 27, 2007, in a previous session of Congress, but was not enacted.
Senator from Wisconsin
Read Text »
Last Updated: Feb 27, 2007
Length: 12 pages
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Jun 27, 2006
Reported by Committee
Last Action: Oct 15, 2009
The “S.” in “S. 316” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 316 — 110th Congress: Preserve Access to Affordable Generics Act. Retrieved from https://www.govtrack.us/congress/bills/110/s316
“S. 316 — 110th Congress: Preserve Access to Affordable Generics Act.” www.GovTrack.us. 2007. August 4, 2015 <https://www.govtrack.us/congress/bills/110/s316>
|title=S. 316 (110th)
|accessdate=August 4, 2015
|author=110th Congress (2007)
|date=January 17, 2007
|quote=Preserve Access to Affordable Generics Act